GlassScriptPhysician profile
Kristin M Cola
NPI 1982945473
$12,485.34
in general payments reported to CMS, 2019-2025
7 companies · $4,890 in 2025
The $4,890 reported for 2025 was more than what 87% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,061 · 2021: $824 · 2022: $310 · 2023: $2,694 · 2024: $2,706 · 2025: $4,890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,580 · Travel and Lodging: $2,621 · Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,580.00 |
| Travel and Lodging | $2,621.46 |
| Food and Beverage | $2,088.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $5,198.41 | 2024-2025 | |
| Medical Device Business Services, INC. | $3,285.91 | 2023-2025 | Expedium, Conduit, Velys |
| Depuy Synthes Sales INC. | $2,826.97 | 2020-2025 | Expedium Verse, Sentio, Expedium |
| Arthrex, INC. | $862.00 | 2020 | |
| Orthopediatrics Corp. | $239.08 | 2024 | |
| Globus Medical, INC. | $58.07 | 2024-2025 | Nvm5 |
| Ethicon US, LLC | $14.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Cola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.